These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31923471)

  • 21. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo controlled phase II clinical trial: Safety and efficacy of combining intranasal insulin & acute exercise.
    Gwizdala KL; Ferguson DP; Kovan J; Novak V; Pontifex MB
    Metab Brain Dis; 2021 Aug; 36(6):1289-1303. PubMed ID: 33856613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.
    Kadowaki T; Kondo K; Sasaki N; Miyayama K; Yokota S; Terata R; Gouda M
    Expert Opin Pharmacother; 2017 Sep; 18(13):1291-1300. PubMed ID: 28741385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.
    Stein MS; Scherer SC; Ladd KS; Harrison LC
    J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intranasal insulin administration on postoperative delirium prevention in elderly cardiac surgery patients: study protocol for a multicenter, double-blind, randomized, controlled trial.
    Nakadate Y; Yamada M; Kusuyama N; Ishii R; Sato H; Schricker T; Tanaka M
    Trials; 2023 Dec; 24(1):822. PubMed ID: 38129907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
    Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S
    J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome.
    Rosenbloom M; Barclay T; Johnsen J; Erickson L; Svitak A; Pyle M; Frey W; Hanson LR
    Drugs R D; 2020 Mar; 20(1):11-15. PubMed ID: 32077057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations.
    Dash S; Xiao C; Morgantini C; Koulajian K; Lewis GF
    Diabetes; 2015 Mar; 64(3):766-74. PubMed ID: 25288674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
    Lundby Christensen L; Almdal T; Boesgaard T; Breum L; Dunn E; Gade-Rasmussen B; Gluud C; Hedetoft C; Jarloev A; Jensen T; Krarup T; Johansen LB; Lund SS; Madsbad S; Mathiesen E; Moelvig J; Nielsen F; Perrild H; Pedersen O; Roeder M; Sneppen SB; Snorgaard O; Tarnow L; Thorsteinsson B; Vaag A; Vestergaard H; Wetterslev J; Wiinberg N;
    Diabetes Obes Metab; 2009 Apr; 11(4):315-22. PubMed ID: 19267709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Arvay L; Liu D; Patel S; von Eynatten M; Woerle HJ
    Clin Ther; 2012 Sep; 34(9):1909-19.e15. PubMed ID: 22939034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
    Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
    Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.
    Yang L; Zhang X; Li S; Wang H; Zhang X; Liu L; Xie A
    Life Sci; 2020 Oct; 259():118159. PubMed ID: 32763288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
    McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
    Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol for adults with type 2 diabetes mellitus.
    Jeyaraman MM; Al-Yousif NSH; Singh Mann A; Dolinsky VW; Rabbani R; Zarychanski R; Abou-Setta AM
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011919. PubMed ID: 31978258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
    Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Jensen T; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
    Osteoporos Int; 2018 Nov; 29(11):2517-2526. PubMed ID: 30027438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
    J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
    Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
    Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
    Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
    Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.